|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1995-9-6
|
|
pubmed:abstractText |
We investigated the clinical utility of macrophage colony-stimulating factor 1 versus CA 125 and the aminoterminal propeptide of type III procollagen in endometrial carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
173
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
112-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:7631667-Adenocarcinoma,
pubmed-meshheading:7631667-CA-125 Antigen,
pubmed-meshheading:7631667-Endometrial Neoplasms,
pubmed-meshheading:7631667-Female,
pubmed-meshheading:7631667-Humans,
pubmed-meshheading:7631667-Middle Aged,
pubmed-meshheading:7631667-Peptide Fragments,
pubmed-meshheading:7631667-Procollagen,
pubmed-meshheading:7631667-Receptor, Macrophage Colony-Stimulating Factor,
pubmed-meshheading:7631667-Tumor Markers, Biological
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Oulu, Finland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
